Industry expresses significant disappointment and concern at the French Senate proposal to restrict Bisphenol A (BPA) in food packaging and in medical devices. The proposal has no safety benefit for consumers and disregards existing European law and risk assessment while disturbing the internal market.
The French Senate´s adoption, on 9 October 2012, of a law proposal to impose a use restriction on all BPA-based food contact packaging in France from July 2015 is not supported by the current weight of scientific evidence. It is in conflict with European Union (EU) food contact regulation and the opinions of the European Food Safety Authority (EFSA), and threatens to create a significant distortion of the internal market for food contact goods in the EU. Furthermore, an additional last minute proposal to restrict certain substances (including BPA) crucial in medical devices used by certain parts of the population may actually cause more harm than good for patients. The move is not based on any scientific consideration, has not been risk assessed and fails to take into account the impact of withdrawing critical medical device applications from the marketplace.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.